Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone

被引:2
|
作者
Arhin, Martin [1 ]
Mobley, Julian [1 ]
Hamad, Hamad [2 ]
Remick, Paul [2 ]
机构
[1] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA
[2] Geisinger Commonwealth Sch Med, Family Med, Scranton, PA USA
关键词
opioid use; methadone clinic; buprenorphine and naloxone; opioid taper; kratom addiction;
D O I
10.7759/cureus.41146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kratom is an unregulated herbal supplement that is growing in popularity in the United States. Its primary active ingredients, mitragynine, and 7-hydroxymitragynine, are partial agonists that act on mu-and delta-opioid receptors in the central nervous system, producing analgesia and a sense of euphoria. Kratom use can lead to addiction and adverse side effects, such as seizures, hallucinations, and coma. This case report presents a male in his 40s with a history of kratom use, who presented to the clinic seeking help for his addiction. The patient had been using kratom for several years to self-medicate for his anxiety and depression and gradually developed a kratom addiction. The patient was successfully treated with buprenorphine/naloxone, which helped alleviate his withdrawal symptoms and allowed him to abstain from kratom. This case underscores the growing issue of kratom addiction in the United States and the critical need for physician awareness in treating withdrawal.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Kratom use disorder: case reports on successful treatment with home induction of buprenorphine-naloxone
    Kiyokawa, Miki
    Kwon, Anthony K.
    Cape, Micaiah C.
    Streltzer, Jon M.
    FAMILY PRACTICE, 2023, 40 (04) : 596 - 598
  • [2] Management of kratom dependence with buprenorphine/naloxone in a veteran population
    Lei, Jamie
    Butz, Amy
    Valentino, Natalie
    SUBSTANCE ABUSE, 2021, 42 (04) : 497 - 502
  • [3] A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone
    Brogdon, Hazel D.
    McPhee, Mackenzie M.
    Paine, Mary F.
    Cox, Emily J.
    Burns, Amy G.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (05) : 606 - 609
  • [4] Buprenorphine-Naloxone in the Setting of Kratom Withdrawal, Opioid Use Disorder, and Stage IV Lung Adenocarcinoma
    Hong, Seokjae
    Zimmerman, Paul E. E.
    Rao, Vineeta
    Markwalter, Daniel W. W.
    JOURNAL OF PALLIATIVE MEDICINE, 2023, 26 (05) : 734 - 736
  • [5] Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: A case report in a young adult
    Schmuhl, Kelsey K.
    Gardner, Spencer M.
    Cottrill, Casey B.
    Bonny, Andrea E.
    SUBSTANCE ABUSE, 2020, 41 (03) : 311 - 314
  • [6] Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance
    Buresh, Megan
    JOURNAL OF ADDICTION MEDICINE, 2018, 12 (06) : 481 - 483
  • [7] Successful Use of Buprenorphine/Naloxone in the Treatment of Tianeptine Withdrawal
    Edgar, Jessica
    Rivera, Jessica
    Rushton, William
    CLINICAL TOXICOLOGY, 2020, 58 (11) : 1218 - 1219
  • [9] Use of Buprenorphine-Naloxone in the Treatment of Tianeptine Use Disorder
    Trowbridge, Paul
    Walley, Alexander Y.
    JOURNAL OF ADDICTION MEDICINE, 2019, 13 (04) : 331 - 333